Trials / Terminated

TerminatedNCT00645255

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Examine the Longer-Term Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Obese Subjects

Status: Terminated
Phase: Phase 3
Study type: Interventional
Enrollment: 466 (actual)

Sponsor: Abbott · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The study was designed to evaluate the long term efficacy and safety of Meridia 15 mg daily in obese subjects.

Conditions

Obesity
Weight Loss

Interventions

Type	Name	Description
DRUG	placebo	placebo one capsule daily
DRUG	sibutramine or placebo	one capsule daily

Timeline

Start date: 1998-09-01
Primary completion: 2003-01-01
First posted: 2008-03-27
Last updated: 2008-03-27

Source: ClinicalTrials.gov record NCT00645255. Inclusion in this directory is not an endorsement.